Compare Stocks → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ETONNASDAQ:EVFMNASDAQ:JAGXNASDAQ:KINNASDAQ:SBBP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeETONEton Pharmaceuticals$3.28+0.9%$3.93$2.42▼$5.81$84.26M1.1767,887 shs23,227 shsEVFMEvofem Biosciences$0.01$0.02$0.01▼$3.75$693K-1.12790,899 shs1.92 million shsJAGXJaguar Health$0.17-5.6%$0.09$0.05▼$1.22$46.41M1.3551.27 million shs39.50 million shsKINKindred Biosciences$9.25$9.22$3.46▼$9.28$420.52M1.3840,890 shs178,496 shsSBBPStrongbridge Biopharma$2.00$2.09$1.85▼$4.26$135.66M1.58866,464 shs684,684 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceETONEton Pharmaceuticals+1.88%+0.93%-17.93%-27.29%-8.96%EVFMEvofem Biosciences+3.25%+6.00%-0.62%-51.82%-99.55%JAGXJaguar Health+14.66%+51.43%+150.21%+81.17%-68.43%KINKindred Biosciences0.00%0.00%0.00%0.00%0.00%SBBPStrongbridge Biopharma0.00%0.00%0.00%0.00%0.00%Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationETONEton Pharmaceuticals2.102 of 5 stars3.55.00.00.00.00.80.0EVFMEvofem BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AJAGXJaguar HealthN/AN/AN/AN/AN/AN/AN/AN/AKINKindred BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ASBBPStrongbridge BiopharmaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceETONEton Pharmaceuticals3.00Buy$10.00204.88% UpsideEVFMEvofem Biosciences2.00HoldN/AN/AJAGXJaguar HealthN/AN/AN/AN/AKINKindred BiosciencesN/AN/AN/AN/ASBBPStrongbridge BiopharmaN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookETONEton Pharmaceuticals$31.64M2.66N/AN/A$0.60 per share5.47EVFMEvofem Biosciences$18.22M0.04$1.28 per share0.01($2.64) per share0.00JAGXJaguar Health$9.76M4.75N/AN/A$0.07 per share2.40KINKindred Biosciences$42.16M9.97N/AN/A$1.75 per share5.29SBBPStrongbridge Biopharma$30.73M4.41N/AN/A$0.98 per share2.04Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateETONEton Pharmaceuticals-$940K-$0.03N/A∞N/A-2.96%-6.21%-3.17%5/9/2024 (Estimated)EVFMEvofem Biosciences$52.98M-$7.62N/A∞N/A290.81%-90.20%331.20%4/26/2024 (Estimated)JAGXJaguar Health-$41.30MN/A0.00∞N/A-423.11%-837.11%-80.76%5/20/2024 (Estimated)KINKindred Biosciences-$21.80M-$0.55N/AN/AN/A-529.26%-54.19%-39.76%N/ASBBPStrongbridge Biopharma-$45.08M-$0.78N/AN/AN/A-115.67%-66.82%-36.21%N/ALatest SBBP, ETON, JAGX, EVFM, and KIN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2024Q4 2023EVFMEvofem BiosciencesN/A-$0.44-$0.44-$0.44N/A$4.84 million3/14/2024Q4 2023ETONEton Pharmaceuticals-$0.04-$0.09-$0.05-$0.09$7.70 million$7.31 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthETONEton PharmaceuticalsN/AN/AN/AN/AN/AEVFMEvofem BiosciencesN/AN/AN/AN/AN/AJAGXJaguar HealthN/AN/AN/AN/AN/AKINKindred BiosciencesN/AN/AN/AN/AN/ASBBPStrongbridge BiopharmaN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioETONEton PharmaceuticalsN/A1.651.60EVFMEvofem BiosciencesN/A0.130.10JAGXJaguar Health6.332.001.34KINKindred Biosciences0.197.027.02SBBPStrongbridge Biopharma0.383.002.95OwnershipInstitutional OwnershipCompanyInstitutional OwnershipETONEton Pharmaceuticals27.86%EVFMEvofem Biosciences0.22%JAGXJaguar Health12.04%KINKindred Biosciences66.89%SBBPStrongbridge Biopharma52.03%Insider OwnershipCompanyInsider OwnershipETONEton Pharmaceuticals13.16%EVFMEvofem Biosciences0.21%JAGXJaguar Health0.02%KINKindred Biosciences13.69%SBBPStrongbridge Biopharma5.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableETONEton Pharmaceuticals3025.69 million22.31 millionOptionableEVFMEvofem Biosciences3553.96 million53.85 millionNot OptionableJAGXJaguar Health49276.22 million276.16 millionNo DataKINKindred Biosciences6345.46 millionN/AOptionableSBBPStrongbridge Biopharma7267.83 millionN/AOptionableSBBP, ETON, JAGX, EVFM, and KIN HeadlinesSourceHeadlineRising Investment in Patient Support Drives a Greater Biopharma Focus on Measurementfiercepharma.com - March 5 at 7:51 AMMatinas BioPharma Holdings Inc (MTNB)investing.com - February 10 at 12:33 PMLytix Biopharma As Share Price (LYTIX.OL)lse.co.uk - November 15 at 2:21 AMAmbrx Biopharma Inc AMAMmorningstar.com - November 4 at 7:36 PMBiopharma’s rapid transition to omnichannel marketingpharmaphorum.com - September 11 at 9:18 AMHILS Hillstream BioPharma, Inc.seekingalpha.com - August 19 at 3:55 PMABUS - Arbutus Biopharma Corporationfinance.yahoo.com - July 1 at 12:38 PMThe Nominees for Best Biopharma CEO of 2015 Are...thestreet.com - April 25 at 8:23 AMDay One Biopharma Shares Rise 13% After Positive Topline Results for Tovorafenibmarketwatch.com - January 11 at 9:43 PMBiopharma Soars to the Computational Cloudsgenengnews.com - October 9 at 12:47 PMAccord BioPharma Partners with StoryMD to Deliver Advanced Prostate Cancer Educational Content to Clinicians and Patientsmarkets.businessinsider.com - September 22 at 10:04 AMStrongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by ...apnews.com - September 23 at 5:49 PMStrongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.finance.yahoo.com - September 23 at 5:49 PMPress Release: Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharmasharecast.com - September 14 at 5:56 PMXeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharmastockhouse.com - September 14 at 5:56 PMStrongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris ...apnews.com - September 9 at 12:31 PMLeading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders ...apnews.com - August 31 at 7:54 AMSecond Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote "FOR" the Transaction With Xeristmcnet.com - August 31 at 7:54 AMSecond Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xerisfinance.yahoo.com - August 31 at 7:54 AMStrongbridge Biopharma plc (NASDAQ: SBBP) Have Dropped -20.16% YTD, What Will Happen Nextmarketingsentinel.com - August 14 at 7:50 AMStrongbridge Biopharma: Q2 Earnings Snapshotsfgate.com - August 5 at 8:43 AMStrongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 5 at 8:43 AMStrongbridge Biopharma plc Announces Commencement of Mailing of Proxy Statementfinance.yahoo.com - August 2 at 9:34 AMStrongbridge Biopharma plc (NASDAQ:SBBP) Shares Plunges -8.08% In A Week – But Can It Keep Rising?marketingsentinel.com - July 31 at 9:50 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsEton PharmaceuticalsNASDAQ:ETONEton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.Evofem BiosciencesNASDAQ:EVFMEvofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.Jaguar HealthNASDAQ:JAGXJaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.Kindred BiosciencesNASDAQ:KINKindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.Strongbridge BiopharmaNASDAQ:SBBPStrongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.